Since amylin protein expression persists in murine islets even after insulin expression has been lost, this new assay can serve as a biomarker of β-cell loss in addition to our previously described insulin biomarker, thereby providing a dual-gene approach for evaluating β-cell loss in T1D. The gene discussed is INS; the disease is type 1 diabetes mellitus.